Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2229 Neoplasms 2031 Lung Neoplasms 1094 Colorectal Neoplasms 1033 Prostatic Neoplasms 892 Carcinoma, Non-Small-Cell Lung 751 Carcinoma, Hepatocellular 672 Stomach Neoplasms 606 Pancreatic Neoplasms 599 Head and Neck Neoplasms 433 Ovarian Neoplasms 430 Colonic Neoplasms 423 Rectal Neoplasms 406 Uterine Cervical Neoplasms 403 Esophageal Neoplasms 346 Brain Neoplasms 329 Neoplasm Metastasis 324 Melanoma 306 Multiple Myeloma 304 Precursor Cell Lymphoblastic Leukemia-Lymphoma 292 Urinary Bladder Neoplasms 289 Leukemia, Myeloid, Acute 276 Lymphoma 268 Liver Neoplasms 253 Endometrial Neoplasms 253 Hematologic Neoplasms 251 Disease 241 Recurrence 225 Glioma 217 Carcinoma, Renal Cell 207

Interventions

Robotic Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Neoadjuvant Chemoimmunotherapy × Clear all

NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Neoadjuvant Chemoimmunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡